CPT Capital

CPT Capital is a venture capital firm established in 2017 and headquartered in London, United Kingdom. The firm specializes in seed-stage investments, primarily focusing on the alternative protein sector, which includes plant-based proteins, recombinant proteins, and cell-based meat. CPT Capital aims to support visionary founders and drive innovation within the food and materials technology revolution, emphasizing the replacement of animals in the supply chain. In addition to its primary focus on alternative proteins, the firm also considers investments across various sectors, including healthcare, information technology, and consumer products, with a geographical reach that spans the United States, Israel, Europe, and Asia.